|Articles|February 1, 2020
- Pharmaceutical Executive-02-01-2020
- Volume 40
- Issue 2
Pharmaceutical Executive, February 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Improving the Link from Lab to Physicianover 6 years ago
Engaging the New HCP in the Digital Worldover 6 years ago
Jay Galeota: A Better Way to Pharmaover 6 years ago
Surfacing Insights: AI and the Physicianover 6 years ago
Becoming a Pharma Industry Leaderover 6 years ago
Unlocking the Black Box of Pharma Pricing in Europeover 6 years ago
The Risks and Rewards of Expedited Reviewover 6 years ago
Using Service to Drive Commercial Valueover 6 years ago
The Roots and Rise of Cell and Gene Therapyover 6 years ago
Pharma Outsourcing: Keys to Productivity in 2020sAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
2
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
3
The Evolving Relationship Between FDA and Biotech
4
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
5